View Cart (0 items)
Pharmaceutical

GlaxoSmithKline Sells Stake in Quest for $1.7 Billion

February 02, 2011
/ Print / Reprints /
| Share More
/ Text Size+

According to MarketWatch, GlaxoSmithKline PLC has sold its entire shareholding in Quest Diagnostics Inc. for about $1.7 billion. Net of tax, GlaxoSmithKline expects to receive cash proceeds of approximately $1.1 billion. The British firm originally acquired the stake as partial consideration for the sale of its laboratories business in 1999 and has since gradually reduced it in stages.

You must login or register in order to post a comment.